\n
Concentration\n<\/h4>\n \n People living with PKU are more likely to struggle with memory, strategy and problem-solving skills5<\/sup><\/p>\n <\/div>\n<\/div>\n\n\n \t
\t
\n
Work & Education\n<\/h4>\n \n The neurocognitive impact of PKU means that people living with PKU are less likely to achieve their senior high school diploma6<\/sup><\/p>\n <\/div>\n<\/div>\n\n\n \t
\t
\n
Relationships\n<\/h4>\n \n A recent study found that over 4 in 10 adults living with PKU feel socially excluded as a result of their condition3<\/sup><\/p>\n <\/div>\n<\/div>\n\n\n \t
\t
\n
Mood and Fatigue \n<\/h4>\n \n 13% of PKU patients reported underlying mood swings and 25% additionally reported experiencing fatigue7<\/sup><\/p>\n <\/div>\n<\/div>\n\n\n \t
\t
\n
Mental Health \n<\/h4>\n \n 50% of adults living PKU reported experiencing symptoms of anxiety or depression3<\/sup><\/p>\n <\/div>\n<\/div>\n\n\n \t
\t
\n
Social Impact \n<\/h4>\n \n People with PKU can experience social difficulties and emotional problems due to their PKU1<\/sup><\/p>\n <\/div>\n<\/div>\n\t\t\t<\/div>\n\t\t<\/div>\n\t<\/div>\n<\/div>\n\n\n
\n\t\t
\n\t\t\t
\n\t\t\t\t
\n\t\t\t\t \t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t \t\t\t\t\t\t\t I usually have emotional instability when my phenylalanine (Phe) levels are high\u2026 I get more sensitive sometimes, I get more irritable. It really affects my emotions.”<\/p>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t -PKU Patient Turkey<\/span><\/cite>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/blockquote>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t<\/div>\n\t<\/div>\n<\/div>\n\n\n
\n
\n \n
\n
What changes does the \u2018Beneath the Surface\u2019 position paper outline?<\/h2>\n To support people living with phenylketonuria, the \u2018Beneath the Surface\u2019 position paper calls for the following changes: <\/p>\n <\/div>\n <\/div>\n <\/div>\n<\/div>\n\n
\n\t
\n\t\t
\n\t\t
\n
\n
\n
<\/span>\n <\/span>\n <\/div>\n 1. Psychological and practical support\n<\/h2>\n <\/div>\n \n
Healthcare service<\/strong> providers should tailor care models to provide psychosocial and practical support<\/strong> for all people living with PKU.<\/p>\n <\/div>\n <\/div>\n \n
\n
\n
<\/span>\n <\/span>\n <\/div>\n 2. Tools to support conversations with clinicians \n<\/h2>\n <\/div>\n \n
Policymakers, clinicians, and the patient community should collaborate to develop tools that allow patients to have meaningful discussions with clinicians<\/strong> on their concentration, mood and quality of life.<\/p>\n <\/div>\n <\/div>\n \n
\n
\n
<\/span>\n <\/span>\n <\/div>\n 3. Individualised care for PKU patients\n<\/h2>\n <\/div>\n \n
Policymakers, clinicians and the patient community should review current management guidelines<\/strong> to identify how individualised care plans can be designed to better support PKU patients.<\/p>\n <\/div>\n <\/div>\n \n
\n
\n
<\/span>\n <\/span>\n <\/div>\n 4. Collaboration across the rare disease community\n<\/h2>\n <\/div>\n \n
Organisations (such as patient advocacy groups) and clinicians working across the rare disease community should collaborate to encourage policymakers to prioritise rare diseases within the health system.<\/strong><\/p>\n <\/div>\n <\/div>\n \t\t<\/div>\n\t<\/div>\n<\/div>\n\n\n
\n\t\t
\n\t\t\t
\n\t\t\t\t
\n\t\t\t\t \t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t \t\t\t\t\t\t\t PKU has many shades. If we focus only on the medical side, we will lose the emotional part of the patient.”<\/p>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t -PKU Patient Italy<\/span><\/cite>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/blockquote>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t<\/div>\n\t<\/div>\n<\/div>\n\n\n
\n\t\t
\n\t\t \t\t\t
References:\n<\/h4>\n\t\t\t\t\t\t \n PKU (2021). How PKU Affects the Brain. Available at: https:\/\/www.pku.com\/about-pku\/phe-in-the-brain. [Accessed April 2023]\n<\/span><\/li>\n Gentille, J.K., Ten Hoedt A.E., Bosch, A.M (2010) Psychosocial aspects of PKU: Hidden disabilities \u2013 A review. Mol Genet Metab, 99 Suppl 1:S64-7. doi: 10.1016\/j.ymgme.2009.10.183.\n<\/span><\/li>\n Ford S, O\u2019Driscoll M, MacDonald A (2018). Living with phenylketonuria: lessons from the PKU community. Mol Genet Metab Rep, 17: pp 57\u201363. 10.1016\/j.ymgmr.2018.10.002\n<\/span><\/li>\n Nunn, R (2017). \u201cIt\u2019s not all in my head!\u201d \u2013 The complex relationship between rare diseases and mental health problems. Orphanet journal of rare diseases, 12(29). Available at: https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-017-0591-7 [Accessed June 2021]\n<\/span><\/li>\n Bartus, A., Palasti, F., Juhasz, E., et al. (2018) The influence of blood phenylalanine levels on neurocognitive function in adult PKU patients. Metabolic Brain Disease, 33, pp. 1609\u20131615 (2018)\n<\/span><\/li>\n M\u00fctze, U., Roth, A., Weigel, J.F.W., et al (2011). Transition of young adults with phenylketonuria from pediatric to adult care Mutze. J Inherit Metab Dis, 34(3), pp. 701-9. doi: 10.1007\/s10545-011-9284-x. Epub 2011 Feb 9.\n<\/span><\/li>\n Borghi, L., Moreschi, C., Toscano, A., et al (2020). The PKU & ME study: A qualitative exploration, through co-creative sessions, of attitudes and experience of the disease among adults with phenylketonuria in Italy. Mol Genet Metab Rep. 2020 Jun; 23: 100585. Published online doi: 10.1016\/j.ymgmr.2020.100585\n<\/span><\/li>\n <\/ol>\n\t\t\t\t\t<\/div>\n\t<\/div>\n<\/div>","protected":false},"excerpt":{"rendered":"","protected":false},"author":2,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"acf":[],"yoast_head":"\nPosition paper | Live Unlimited PKU<\/title>\n \n \n \n \n \n \n \n \n \n \n \n